Literature DB >> 18262170

Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A).

Tomohiro Terada1, Ken-ichi Inui.   

Abstract

Vectorial secretion of cationic compounds across tubular epithelial cells is an important function of the kidney. This uni-directed transport is mediated by two cooperative functions, which are membrane potential-dependent organic cation transporters at the basolateral membranes and H+/organic cation antiporters at the brush-border membranes. More than 10 years ago, the basolateral organic cation transporters (OCT1-3/SLC22A1-3) were isolated, and molecular understandings for the basolateral entry of cationic drugs have been greatly advanced. However, the molecular nature of H+/organic cation antiport systems remains unclear. Recently, mammalian orthologues of the multidrug and toxin extrusion (MATE) family of bacteria have been isolated and clarified to function as H+/organic cation antiporters. In this commentary, the molecular characteristics and pharmacokinetic roles of mammalian MATEs are critically overviewed focusing on the renal secretion of cationic drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18262170     DOI: 10.1016/j.bcp.2007.12.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  38 in total

1.  Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.

Authors:  Fabian Müller; Jörg König; Hartmut Glaeser; Ingrid Schmidt; Oliver Zolk; Martin F Fromm; Renke Maas
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

Review 2.  Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

Authors:  M A Daniels; C Kan; D M Willmes; K Ismail; F Pistrosch; D Hopkins; G Mingrone; S R Bornstein; A L Birkenfeld
Journal:  Pharmacogenomics J       Date:  2016-07-19       Impact factor: 3.550

3.  Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats.

Authors:  Kunio Fujiwara; Masashi Shin; Tsubasa Miyazaki; Yasuhiro Maruta
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

4.  An in vivo role of Mrp2 in the rat hepatocytes by immunocytochemistry for amoxicillin using the transporter-deficient EHBR.

Authors:  Kunio Fujiwara; Masashi Shin; Yohei Yoshizaki; Tsubasa Miyazaki; Tetsuya Saita
Journal:  J Mol Histol       Date:  2012-03-25       Impact factor: 2.611

5.  Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects.

Authors:  Hwa Yoon; Hea-Young Cho; Hee-Doo Yoo; Se-Mi Kim; Yong-Bok Lee
Journal:  AAPS J       Date:  2013-02-16       Impact factor: 4.009

6.  Characterization of the disposition and toxicokinetics of N-butylpyridinium chloride in male F-344 rats and female B6C3F1 mice and its transport by organic cation transporter 2.

Authors:  Y Cheng; S H Wright; M J Hooth; I G Sipes
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

Review 7.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

8.  MATE1 has an external COOH terminus, consistent with a 13-helix topology.

Authors:  Xiaohong Zhang; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-10

9.  Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats.

Authors:  Koji Yokoo; Risa Murakami; Takanobu Matsuzaki; Kanako Yoshitome; Akinobu Hamada; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2009-07-24       Impact factor: 2.801

10.  Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study.

Authors:  Matthijs L Becker; Loes E Visser; Ron H N van Schaik; Albert Hofman; André G Uitterlinden; Bruno H Ch Stricker
Journal:  Diabetes       Date:  2009-02-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.